Literature DB >> 16898567

A public health approach to the diabetes epidemic: New York City's diabetes registry.

Mary Ann Banerji1, Robyn B Stewart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16898567     DOI： 10.1007/s11892-006-0029-4

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


× No keyword cloud information.
  20 in total

1.  Standards of medical care in diabetes--2006.

Authors: 
Journal:  Diabetes Care       Date:  2006-01       Impact factor: 19.112

2.  Monitoring diabetes treatment in New York City.

Authors: 
Journal:  Lancet       Date:  2006-01-21       Impact factor: 79.321

3.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors:  David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

4.  Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.

Authors:  X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

Review 5.  Critical features for a successful implementation of a diabetes registry.

Authors:  Robert A Gabbay; Leila Khan; Kevin L Peterson
Journal:  Diabetes Technol Ther       Date:  2005-12       Impact factor: 6.118

6.  A randomized trial of three diabetes registry implementation strategies in a community internal medicine practice.

Authors:  Robert J Stroebel; Sidna M Scheitel; John S Fitz; Ruth A Herman; James M Naessens; Christopher G Scott; David A Zill; Lisa Muller
Journal:  Jt Comm J Qual Improv       Date:  2002-08

7.  Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.

Authors:  Jean-Louis Chiasson; Robert G Josse; Ramon Gomis; Markolf Hanefeld; Avraham Karasik; Markku Laakso
Journal:  JAMA       Date:  2003-07-23       Impact factor: 56.272

8.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

Authors:  Peter Gaede; Pernille Vedel; Nicolai Larsen; Gunnar V H Jensen; Hans-Henrik Parving; Oluf Pedersen
Journal:  N Engl J Med       Date:  2003-01-30       Impact factor: 91.245

9.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women.

Authors:  Thomas A Buchanan; Anny H Xiang; Ruth K Peters; Siri L Kjos; Aura Marroquin; Jose Goico; Cesar Ochoa; Sylvia Tan; Kathleen Berkowitz; Howard N Hodis; Stanley P Azen
Journal:  Diabetes       Date:  2002-09       Impact factor: 9.461
View more
  1 in total

1.  Tracking diabetes: New York City's A1C Registry.

Authors:  Shadi Chamany; Lynn D Silver; Mary T Bassett; Cynthia R Driver; Diana K Berger; Charlotte E Neuhaus; Namrata Kumar; Thomas R Frieden
Journal:  Milbank Q       Date:  2009-09       Impact factor: 4.911
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.